Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry studyThomas Marjot, Gwilym J. Webb, Andrew M. Moon et al.|Journal of Hepatology|2020Cited by 525
Is Percutaneous Drainage the New Gold Standard in the Management of Emphysematous Pyelonephritis? Evidence From a Systematic ReviewBhaskar Somani, James N’Dow, Jonathan Cook et al.|The Journal of Urology|2008Cited by 292
Placebo comparator group selection and use in surgical trials: the ASPIRE project including expert workshopDavid Beard, Jonathan Cook|Health Technology Assessment|2021Cited by 8
Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study)Abhishek Abhishek, Jonathan Cook|BMJ Open|2022Cited by 7